NDC 70069-072-01 - NALOXONE HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70069-072
- Requested NDC
- 70069-072-01
- Package NDCs from labels
- 70069-072-01, 70069-072-10
- Manufacturer
- HF Acquisition Co. LLC. DBA HealthFirst
- Effective date
- 2026-03-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NALOXONE HYDROCHLORIDE - HF Acquisition Co. LLC. DBA HealthFirst | HF Acquisition Co. LLC. DBA HealthFirst | 2026-03-19 | HUMAN PRESCRIPTION DRUG LABEL |
| Naloxone Hydrochloride - ProPharma Distribution | ProPharma Distribution | 2025-09-19 | HUMAN PRESCRIPTION DRUG LABEL |
| NALOXONE HYDROCHLORIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2025-01-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Naloxone Hydrochloride - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2024-12-10 | HUMAN PRESCRIPTION DRUG LABEL |
| NALOXONE - Somerset Therapeutics, LLC | Somerset Therapeutics Limited | Somerset Therapeutics, LLC | Somerset Therapeutics Limited | 2023-12-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70069-072-01 | Naloxone Hydrochloride | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 9 | |
| 70069-072-01 | Naloxone Hydrochloride | 10 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 10 | 9 | |
| 70069-072-10 | Naloxone Hydrochloride | 10 in 1 BOX | INJECTION, SOLUTION | 10 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70069-072-01 | ML - Milliliter | 70069-072 | de758f4e-bb4d-4282-9069-eba7af7f00b5 | 1 | 2017-09-11 |
| 70069-072-10 | ML - Milliliter | 70069-072 | dc1171ee-21fa-403b-8889-a8dee04a1738 | 1 | 2017-09-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0.9%saline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 49e7b329-e4e5-6991-e063-6294a90ac817 | 2026-02-03 | Warnings | 451W47IQ8X |
| Adrenal Support | ADRENALINUM, BERBERIS VULGARIS, ARGENTUM NITRICUM, NATRUM MURIATICUM, VANADIUM METALLICUM, OLEUM MORRHUAE, PETROLEUM | NaturalCare | cee52757-a86e-4251-b65f-954ac85f4e7e | 2026-01-30 | Warnings | 451W47IQ8X |
| Vital Female Sexual Energy | AGNUS CASTUS, ARNICA MONTANA, AVENA SATIVA, CAULOPHYLLUM THALICTROIDES, CINCHONA OFFICINALIS, DAMIANA, HYPOPHYSIS SUIS, L-ARGININE, NATRUM MURIATICUM, OOPHORINUM SUIS, PHOSPHORICUM ACIDUM, SABAL SERRULATA, SEPIA, THUJA OCCIDENTALIS | Liddell Laboratories, Inc. | 7b15d6fa-eb04-41d2-8a01-6e7408ccf4d3 | 2026-01-30 | Warnings | 451W47IQ8X |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | 451W47IQ8X |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Camber Pharmaceuticals, Inc. | 221195e4-de08-414c-af08-a611a74789de | 2026-01-30 | Warnings, Adverse reactions | F850569PQR |
| CVS ULTRA FINE MOISTURIZING SALINE MIST | NASAL MIST | CVS | 44821c47-63f9-5d0a-e063-6394a90a555d | 2026-01-29 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Nephron Pharmaceuticals Corporation | a4edf2d5-a9ff-30d4-e053-2995a90a5650 | 2026-01-26 | Warnings, Adverse reactions | 451W47IQ8X |
| INSULIN DILUTING MEDIUM FOR Kirsty | WATER | Biocon Biologics Inc. | 3db1d482-7e1f-aec6-79ef-3f305b4d8277 | 2026-01-20 | Warnings, Adverse reactions | 059QF0KO0R |
| Sodium Chloride | SODIUM CHLORIDE | ProPharma Distribution | 48d73434-e65b-dc98-e063-6294a90affa2 | 2026-01-20 | Adverse reactions | 451W47IQ8X |
| Equate Comfort Flow Sinus wash | SINUS WASH | WALMART INC | 9e911eef-ca99-9902-e053-2a95a90aab0e | 2026-01-19 | Warnings | 451W47IQ8X |
| EQUATE PREMIUM SALINE | SODIUM CHLORIDE 0.65% | Walmart Stores, Inc. | 1e17f022-f513-140d-e063-6394a90a379e | 2026-01-19 | Warnings | 451W47IQ8X |
| Sodium chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | d98bf9f7-30ec-4927-a577-cabad192cb18 | 2026-01-19 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride Hypertonicity | SODIUM CHLORIDE | CVS Pharmacy | 9245d842-7f78-42d8-83ba-8eb9ec8dbc0d | 2026-01-15 | Warnings | 451W47IQ8X |
| Sodium Chloride Hypertonicity | SODIUM CHLORIDE | CVS PHARMACY | d5cc6cd1-ddf8-4f5b-a021-204cdda0db94 | 2026-01-15 | Warnings | 451W47IQ8X |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | AvKARE | 1766a7f1-d301-945f-e063-6294a90ac6f4 | 2026-01-14 | Warnings | F850569PQR |
| Walgreens Sterile Soothing Eye Wash | PURIFIED WATER | Walgreens | a62e3294-abd6-48dc-81b1-62a809bdc968 | 2026-01-14 | Warnings | 059QF0KO0R |
| RiVive | NALOXONE HYDROCHLORIDE | Harm Reduction Therapeutics, Inc. | 1c4f1b9d-1c70-4666-a90e-2f5d2c670d4d | 2026-01-13 | Warnings | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Sina Health Inc | 2879294f-9af9-459e-e063-6394a90a0820 | 2026-01-12 | Warnings, Adverse reactions | F850569PQR |
| Constipation Relief | ALUMINUM OXIDE, BRYONIA ALBA ROOT, SODIUM CHLORIDE, GRAPHITE, SILICON DIOXIDE | Homeocare Laboratories | 62374240-cd14-44e2-9405-5f8996faf047 | 2026-01-12 | Warnings | 451W47IQ8X |
| Luffa | LUFFA, HYDRASTIS CANADENSIS, MERCURIUS SULPH. RUB, ALLIUM CEPA, NATRUM MURITICUM, PHOSPHORUS, EUPATORIUM PERF, STICTA | Marco Pharma International LLC. | 7dbb79de-c3f5-4245-884a-a6bd29bb861c | 2026-01-12 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.